BACE1- and BACE2-expressing Human Cells: CHARACTERIZATION OF β-AMYLOID PRECURSOR PROTEIN-DERIVED CATABOLITES, DESIGN OF A NOVEL FLUORIMETRIC ASSAY, AND IDENTIFICATION OF NEW IN VITRO INHIBITORS
Open Access
- 11 July 2003
- journal article
- Published by Elsevier
- Vol. 278 (28) , 25859-25866
- https://doi.org/10.1074/jbc.m302622200
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Amyloid Precursor Protein, Presenilins, and α-Synuclein: Molecular Pathogenesis and Pharmacological Applications in Alzheimer’s DiseasePharmacological Reviews, 2002
- Human β-secretase and Alzheimer’s diseaseEmerging Therapeutic Targets, 2001
- The multiple paradoxes of presenilinsJournal of Neurochemistry, 2001
- Presenilin and γ‐secretase: structure meets functionJournal of Neurochemistry, 2001
- Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activityNature, 1999
- Purification and cloning of amyloid precursor protein β-secretase from human brainNature, 1999
- Identification of a Novel Aspartic Protease (Asp 2) as β-SecretaseMolecular and Cellular Neuroscience, 1999
- β-Secretase Cleavage of Alzheimer's Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACEScience, 1999
- Translating cell biology into therapeutic advances in Alzheimer's diseaseNature, 1999
- Processing of the β‐Amyloid Precursor Protein and Its Regulation in Alzheimer's DiseaseJournal of Neurochemistry, 1995